Insider Transactions in Q1 2025 at Unitedhealth Group Inc (UNH)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 21
2025
|
Heather Cianfrocco Chief Executive Officer, Optum |
SELL
Payment of exercise price or tax liability
|
Direct |
1,001
-1.45%
|
$466,466
$466.42 P/Share
|
Feb 21
2025
|
Thomas E Roos Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
694
-0.77%
|
$323,404
$466.42 P/Share
|
Feb 21
2025
|
Christopher R Zaetta EVP & Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
429
-1.35%
|
$199,914
$466.42 P/Share
|
Feb 21
2025
|
Timothy John Noel Chief Executive Officer, UHC |
SELL
Payment of exercise price or tax liability
|
Direct |
630
-2.19%
|
$293,580
$466.42 P/Share
|
Feb 21
2025
|
Andrew Witty CEO, UHG |
SELL
Payment of exercise price or tax liability
|
Direct |
3,911
-1.14%
|
$1,822,526
$466.42 P/Share
|
Feb 21
2025
|
John F Rex President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,579
-0.46%
|
$1,201,814
$466.42 P/Share
|
Feb 21
2025
|
Erin Mc Sweeney EVP & Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
739
-2.11%
|
$344,374
$466.42 P/Share
|
Feb 20
2025
|
Heather Cianfrocco Chief Executive Officer, Optum |
BUY
Grant, award, or other acquisition
|
Direct |
8,346
+15.84%
|
-
|
Feb 20
2025
|
Heather Cianfrocco Chief Executive Officer, Optum |
SELL
Payment of exercise price or tax liability
|
Direct |
1,698
-8.04%
|
$852,396
$502.42 P/Share
|
Feb 20
2025
|
Thomas E Roos Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,369
+4.34%
|
-
|
Feb 20
2025
|
Christopher R Zaetta EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,484
+24.55%
|
-
|
Feb 20
2025
|
Timothy John Noel Chief Executive Officer, UHC |
BUY
Grant, award, or other acquisition
|
Direct |
6,448
+27.9%
|
-
|
Feb 20
2025
|
Timothy John Noel Chief Executive Officer, UHC |
SELL
Payment of exercise price or tax liability
|
Direct |
882
-13.16%
|
$442,764
$502.42 P/Share
|
Feb 20
2025
|
Andrew Witty CEO, UHG |
BUY
Grant, award, or other acquisition
|
Direct |
27,097
+10.63%
|
-
|
Feb 20
2025
|
Andrew Witty CEO, UHG |
SELL
Payment of exercise price or tax liability
|
Direct |
7,356
-6.58%
|
$3,692,712
$502.42 P/Share
|
Feb 20
2025
|
John F Rex President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
19,227
+4.85%
|
-
|
Feb 20
2025
|
John F Rex President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,787
-3.09%
|
$2,905,074
$502.42 P/Share
|
Feb 20
2025
|
Erin Mc Sweeney EVP & Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,161
+21.44%
|
-
|
Feb 20
2025
|
Erin Mc Sweeney EVP & Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,232
-11.55%
|
$618,464
$502.42 P/Share
|
Feb 14
2025
|
Erin Mc Sweeney EVP & Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
138
-1.94%
|
$72,174
$523.51 P/Share
|
Feb 14
2025
|
Thomas E Roos Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
300
-1.03%
|
$156,900
$523.51 P/Share
|
Feb 14
2025
|
Andrew Witty CEO, UHG |
SELL
Payment of exercise price or tax liability
|
Direct |
1,066
-1.1%
|
$557,518
$523.51 P/Share
|
Feb 14
2025
|
Timothy John Noel Chief Executive Officer, UHC |
SELL
Payment of exercise price or tax liability
|
Direct |
113
-2.6%
|
$59,099
$523.51 P/Share
|
Feb 14
2025
|
Christopher R Zaetta EVP & Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
176
-2.38%
|
$92,048
$523.51 P/Share
|
Feb 14
2025
|
Heather Cianfrocco Chief Executive Officer, Optum |
SELL
Payment of exercise price or tax liability
|
Direct |
182
-1.08%
|
$95,186
$523.51 P/Share
|
Feb 14
2025
|
John F Rex President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
799
-0.45%
|
$417,877
$523.51 P/Share
|
Feb 07
2025
|
John F Rex President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,206
-7.93%
|
$8,074,386
$531.48 P/Share
|
Feb 07
2025
|
John F Rex President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,504
+11.74%
|
$2,754,432
$108.97 P/Share
|
Jan 17
2025
|
Timothy Patrick Flynn Director |
BUY
Open market or private purchase
|
Indirect |
1,000
+18.18%
|
$511,000
$511.57 P/Share
|
Jan 02
2025
|
Frederick William Mcnabb Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
190
+1.39%
|
-
|
Jan 02
2025
|
Charles D. Baker Director |
BUY
Grant, award, or other acquisition
|
Direct |
174
+17.88%
|
-
|
Jan 02
2025
|
Rice Valerie Md Montgomery Director |
BUY
Grant, award, or other acquisition
|
Direct |
186
+2.98%
|
-
|
Jan 02
2025
|
Stephen J Hemsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
283
+0.03%
|
-
|
Jan 02
2025
|
Paul R Garcia Director |
BUY
Grant, award, or other acquisition
|
Direct |
174
+3.7%
|
-
|
Jan 02
2025
|
Timothy Patrick Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
186
+2.05%
|
-
|
Jan 02
2025
|
John H Noseworthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
186
+3.24%
|
-
|
Jan 02
2025
|
Michele J Hooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
112
+0.28%
|
-
|
Jan 02
2025
|
Gil Kristen Director |
BUY
Grant, award, or other acquisition
|
Direct |
174
+5.83%
|
-
|